J. San

Martín Prediabetes : what are we talking about ?

J. San, 2021 .

Burosumab versus continuation of conventional therapy in children with X-linked hypophosphatemia: a randomised, active-controlled, open-label, phase 3 trial

Farzana, F. Glorieux, H. Cheong, 2020 .